Literature DB >> 17942812

Localization of dystonic muscles with 18F-FDG PET/CT in idiopathic cervical dystonia.

Duk Hyun Sung1, Joon Young Choi, Du-Hwan Kim, Eun-Sang Kim, Young-Ik Son, Young-Seok Cho, Su Jin Lee, Kyung-Han Lee, Byung-Tae Kim.   

Abstract

UNLABELLED: The purpose of this study was to investigate whether (18)F-FDG PET/CT is useful for localizing dystonic cervical muscles in patients with idiopathic cervical dystonia (ICD) by comparing disease severity before and disease severity after botulinum toxin (BT) injection into hypermetabolic muscles.
METHODS: Six patients with ICD underwent (18)F-FDG PET/CT. Dystonic muscles suitable for BT injection therapy were defined as those showing diffusely increased (18)F-FDG uptake.
RESULTS: Hypermetabolic cervical muscles were identified in all 6 patients. In 2 patients who underwent PET/CT both in a supine position and in a sitting position during (18)F-FDG uptake, abnormal hypermetabolic muscles were observed by PET/CT only when patients were in the sitting position with their heads and necks in the adopted abnormal involuntary posture. Symptoms were significantly improved in 4 patients who underwent BT injection therapy guided by PET/CT and who were clinically monitored.
CONCLUSION: (18)F-FDG PET/CT is potentially useful for identifying dystonic cervical muscles for BT therapy in patients with ICD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942812     DOI: 10.2967/jnumed.107.044024

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

Review 1.  Anterocollis and camptocormia in parkinsonism: a current assessment.

Authors:  Gonzalo J Revuelta
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

2.  Fluoroscopy and sonographic guided injection of obliquus capitis inferior muscle in an intractable occipital neuralgia.

Authors:  Ok Sun Kim; Seung Min Jeong; Ji Young Ro; Duck Kyoung Kim; Young Cho Koh; Young Sin Ko; So Dug Lim; Hwa Yong Shin; Hae Kyoung Kim
Journal:  Korean J Pain       Date:  2010-03-10

3.  An ¹⁸F-FDG PET study of cervical muscle in parkinsonian anterocollis.

Authors:  Gonzalo J Revuelta; Jaime Montilla; Michael Benatar; Alan Freeman; Thomas Wichmann; Hyder A Jinnah; Mahlon R Delong; Stewart A Factor
Journal:  J Neurol Sci       Date:  2014-03-18       Impact factor: 3.181

4.  Comparison between (18)F-FDG PET/CT and EMG Mapping for Identifying Dystonic Superficial Muscles in Primary Cervical Dystonia: Preliminary Results.

Authors:  Su Jin Jang; Joon Young Choi; Duk Hyun Sung; Kwang Hong Park; Ji Young Lee; Sook Kyung Cho; Jang Yu; Kyung-Han Lee; Byung-Tae Kim
Journal:  Nucl Med Mol Imaging       Date:  2010-02-26

Review 5.  Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement.

Authors:  Axel Schramm; Tobias Bäumer; Urban Fietzek; Susanne Heitmann; Uwe Walter; Wolfgang H Jost
Journal:  J Neural Transm (Vienna)       Date:  2014-12-30       Impact factor: 3.575

6.  Postoperative 18F-FDG-PET/CT documents efficacy of selective peripheral denervation for treating cervical dystonia.

Authors:  Isamu Miura; Shiro Horisawa; Takakazu Kawamata; Takaomi Taira
Journal:  Surg Neurol Int       Date:  2022-07-15

7.  Usefulness of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography in management of cervical dystonia.

Authors:  Han Byul Lee; Young-Sil An; Hyun Young Lee; Jee Hyun Hwang; Hyun Jung Lee; Kil Yong Jeong; Jong Woo Kim; Shin-Young Yim
Journal:  Ann Rehabil Med       Date:  2012-12-28

8.  Threshold of Clinical Severity of Cervical Dystonia for Positive (18)F-FDG PET/CT.

Authors:  Hyun Jung Lee; Young-Sil An; Young-Whan Ahn; Shin-Young Yim
Journal:  Ann Rehabil Med       Date:  2013-12-23

Review 9.  A methodological approach for botulinum neurotoxin injections to the longus colli muscle in dystonic anterocollis: A case series of 4 patients and a literature review.

Authors:  Yury Seliverstov; Sergey Arestov; Sergey Klyushnikov; Yuliya Shpilyukova; Sergey Illarioshkin
Journal:  J Clin Neurosci       Date:  2020-08-26       Impact factor: 1.961

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.